Your browser doesn't support javascript.
loading
Mitochondrial Respiration Defects in Single-Ventricle Congenital Heart Disease.
Xu, Xinxiu; Lin, Jiuann-Huey Ivy; Bais, Abha S; Reynolds, Michael John; Tan, Tuantuan; Gabriel, George C; Kondos, Zoie; Liu, Xiaoqin; Shiva, Sruti S; Lo, Cecilia W.
Afiliação
  • Xu X; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Lin JI; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Bais AS; Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Reynolds MJ; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Tan T; School of Medicine, Pittsburgh Heart, Lung, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, United States.
  • Gabriel GC; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Kondos Z; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Liu X; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Shiva SS; Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Lo CW; School of Medicine, Pittsburgh Heart, Lung, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, United States.
Front Cardiovasc Med ; 8: 734388, 2021.
Article em En | MEDLINE | ID: mdl-34631832
ABSTRACT

Background:

Congenital heart disease (CHD) with single-ventricle (SV) physiology is now survivable with a three-stage surgical course ending with Fontan palliation. However, 10-year transplant-free survival remains at 39-50%, with ventricular dysfunction progressing to heart failure (HF) being a common sequela. For SV-CHD patients who develop HF, undergoing the surgical course would not be helpful and could even be detrimental. As HF risk cannot be predicted and metabolic defects have been observed in Ohia SV-CHD mice, we hypothesized that respiratory defects in peripheral blood mononuclear cells (PBMCs) may allow HF risk stratification in SV-CHD.

Methods:

SV-CHD (n = 20), biventricular CHD (BV-CHD; n = 16), or healthy control subjects (n = 22) were recruited, and PBMC oxygen consumption rate (OCR) was measured using the Seahorse Analyzer. Respiration was similarly measured in Ohia mouse heart tissue.

Results:

Post-Fontan SV-CHD patients with HF showed higher maximal respiratory capacity (p = 0.004) and respiratory reserve (p < 0.0001), parameters important for cell stress adaptation, while the opposite was found for those without HF (reserve p = 0.037; maximal p = 0.05). This was observed in comparison to BV-CHD or healthy controls. However, respiration did not differ between SV patients pre- and post-Fontan or between pre- or post-Fontan SV-CHD patients and BV-CHD. Reminiscent of these findings, heart tissue from Ohia mice with SV-CHD also showed higher OCR, while those without CHD showed lower OCR.

Conclusion:

Elevated mitochondrial respiration in PBMCs is correlated with HF in post-Fontan SV-CHD, suggesting that PBMC respiration may have utility for prognosticating HF risk in SV-CHD. Whether elevated respiration may reflect maladaptation to altered hemodynamics in SV-CHD warrants further investigation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2021 Tipo de documento: Article